Additionally, the tumour EGCs can also present a unique reactive phenotype, with increased expression of genes correlated with astrogliosis (e.g. Lcn2 and Timp1) and immunomodulatory functions (e.g. Ccl2 and Il6). This evidence concerns the gene IL6 and neoplasm.